Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

114.51
+1.431.26%
Post-market: 114.900.3900+0.34%19:33 EDT
Volume:290.40K
Turnover:33.26M
Market Cap:1.03B
PE:92.78
High:115.80
Open:115.15
Low:114.21
Close:113.08
52wk High:118.00
52wk Low:85.91
Shares:8.99M
Float Shares:8.99M
Volume Ratio:0.93
T/O Rate:3.23%
Dividend:2.17
Dividend Rate:1.90%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):147.47

Loading ...

Merck (MRK) Wins FDA Approval For First Oral PCSK9 Cholesterol Drug

Simply Wall St.
·
2 hours ago

AbbVie Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
6 hours ago

Merck Files Form 3 for EVP, CIDO Gaurav Gupta

Reuters
·
7 hours ago

World's Largest Companies by Market Cap (August 2026): Nvidia Retains Top Spot, SpaceX Rebounds 32%, Semiconductor Sector Diverges

TradingKey
·
7 hours ago

H.C. Wainwright says Novartis success in RMS trials does not impact TG’s Briumvi

TIPRANKS
·
Yesterday

Rpt: Who: Ervebo Should Only be Used for Bundibugyo Virus (Bvdv) Within the Context of a Research Protocol at This Time

THOMSON REUTERS
·
Yesterday

Novartis MS Trials Open Door to Multibillion-Dollar Sales Opportunity

Dow Jones
·
Yesterday

Novartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials

TIPRANKS
·
Yesterday

Novartis AG Stock (NVS) Moved Up by 6.54% on Sep 1: Drivers Behind the Movement

TradingKey
·
Yesterday

Novartis's Multiple Sclerosis Trial Results Match Best Hopes

Dow Jones
·
Yesterday

US Stock Alert: Novartis Gains 5% On Positive Late-Stage Trial Results For MS Oral Therapy

Stock News
·
Yesterday

Novartis up Nearly 6%, on Pace for Largest Percent Increase Since March 2023

Dow Jones
·
Yesterday

Sector Update: Healthcare Stocks Mixed Premarket Tuesday

MT Newswires Live
·
Yesterday

【US Pre-Market】US Futures and Chip Stocks Fall as Global Bond Sell-Off Deepens; Gold Drops Below $4,400, Brent Crude Tops $92

TradingKey
·
Yesterday

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Yesterday

Why Novartis Stock is Heading for Its Best Day Since 2023 After 3 Patient Deaths

Dow Jones
·
Yesterday

NetraMark Appoints Abivax Regulatory Chief Keith Fournier to Board

Reuters
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Incyte (INCY) and Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Novartis Shares Climb After Pill Hits Goals in Multiple Sclerosis Trials

Dow Jones
·
Yesterday

Novartis announces results from Phase III Remodel-1/-2 trials of remibrutinib

TIPRANKS
·
Yesterday